unknown
Stage
1
Investors
About
Apeikon Therapeutics is a UK-based biotechnology company developing novel therapeutics for neurodegenerative diseases such as Alzheimer's and Parkinson's. They leverage a proprietary platform focused on neuroinflammation and mitochondrial dysfunction to identify drug candidates.
Explore Apeikon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.